DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Acceptability of the NuvaRing Among Students

Information source: University of Chicago
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Birth Control Compliance

Intervention: Ortho Tri-cyclen Lo (Drug); NuvaRing (Device)

Phase: Phase 4

Status: Completed

Sponsored by: University of Chicago

Official(s) and/or principal investigator(s):
Melissa L Gilliam, MD, MPH, Principal Investigator, Affiliation: University of Chicago, Section of Family Planning

Summary

The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.

Clinical Details

Official title: Acceptability of the NuvaRing Among College and Graduate Students

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Primary outcome: Adherence Rate (Rate of Perfect Method Use)

Secondary outcome:

Satisfaction Rate

Continuation Rate

Detailed description: For many women, college is a time of great change that affects one's social and behavioral practices, including sexual behavior. The first part of the NuvaRing ® Acceptability study is an online survey, developed in conjunction with the University of Illinois's Survey Research Laboratory, which examines women's attitudes and beliefs regarding various methods of birth control. The second part of the study is a comparison trial in which the women are randomized to either the NuvaRing ® vaginal contraceptive ring or a low dose oral contraceptive. The women are followed for three months to assess compliance, side effects, overall acceptability and intent to continue use of the method. Ultimately, we would like college women to be well informed about various methods of contraception available to them and to choose the contraceptive method that best suits their lifestyle.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- over 18

- student enrolled in college or graduate program

- Not have used the contraceptive patch or oral contraceptives within the last month

- Never have used a contraceptive vaginal ring

- Interested in using hormonal contraceptives, specifically NuvaRing and oral

contraceptive pills for next 3 months

- In general good health

- Premenopausal with the ability to menstruate

Exclusion Criteria:

- Known or suspected pregnancy

- Pregnancy within 2 months of trial medication

- Past use of any contraceptive vaginal ring

- Hypersensitivity or allergy to NuvaRing or Oral Contraceptives

- Use of investigational drug within 2 months of start of trial medication

- Use of the contraceptive patch or oral contraceptives within past month

- Use of any injectable contraception within 6 months of trial medication

- Planning pregnancy in next 6 months

Locations and Contacts

University of Chicago, Chicago, Illinois 60637, United States

University of Chicago, Section of Family Planning, Chicago, Illinois 60637, United States

University of Illinois, Chicago, Illinois, United States

Additional Information

Section of Family Planning web site

Related publications:

Gilliam M, Holmquist S, Berlin A. Factors associated with willingness to use the contraceptive vaginal ring. Contraception. 2007 Jul;76(1):30-4. Epub 2007 May 24.

Starting date: July 2008
Last updated: June 24, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017